Dopamine in Health and Disease 2.0
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 29158
Special Issue Editor
Interests: brain development and regeneration; development of dopamine and GABA neurons; control of gene expression; transgenic models; evolution of developmental mechanisms; zebrafish models of disease including Parkinson's disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The neurotransmitter dopamine plays crucial roles within the central nervous system, influencing multiple neural pathways and associated behaviors such as locomotion, reward mechanisms, neuroendocrine control, and emotion, to name but a few. Dysfunction of dopamine systems, including degeneration of dopamine neurons, is associated with numerous diseases. Some of the medications used to treat these diseases act by altering the effects of dopamine. This Special Issue on “Dopamine in Health and Disease 2.0” will present a selection of original research papers or reviews that address such topics as cellular mechanisms of disease affecting dopaminergic systems, genetic influences on dopamine neuron health and function, animal models of dopamine neuron loss and regeneration, and novel therapeutics for pathologies that involve dopamine neurons.
Prof. Dr. Marc Ekker
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- dopamine
- disease models
- mitochondria
- Parkinson’s disease
- schizophrenia
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Related Special Issue
- Dopamine in Health and Disease in Biomedicines (14 articles)